Bluefin Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-28,360	Closed	-$1.2M	–	545
2014 Q1	$1.2M	Buy	+28,360	New	+$1.2M	0.08%	165